(Q77590570)

English

U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts

scientific article published on 01 November 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

T T Rohn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

L K Nelson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

G Waeg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M T Quinn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

0 references

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1371-1379

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Oxidative stress, caloric restriction, and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

The free radical theory of aging matures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Free radicals in disease processes: a compilation of cause and consequence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Oxidative stress: the paradox of aerobic life

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Lipid peroxidation, antioxidant protection and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Free radicals as mediators of tissue injury and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Immunocytochemical detection of lipid peroxidation in phagosomes of human neutrophils: correlation with expression of flavocytochrome b

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Increased lipid peroxidation in children with autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Age-related changes in tissue content of malondialdehyde-modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Role of lipid peroxidation and the glutathione-dependent antioxidant system in the impairment of endothelium-dependent relaxations with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Characterization of drugs as antioxidant prophylactics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Antioxidant action of lazaroids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Inhibition of Ca2+-pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1- pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Gastric injury induced by ethanol and ischemia-reperfusion in the rat. Differing roles for lipid peroxidation and oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Microassay of superoxide anion scavenging activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

The lateral organization of components of the membrane skeleton and superoxide generation in the plasma membrane of stimulated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

4-Hydroxynonenal-induced cell death in murine alveolar macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

4-hydroxynonenal inhibits Na(+)-K(+)-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Profiles of hepatic cellular protein adduction by malondialdehyde and 4-hydroxynonenal. Studies with isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Immunological evidence for increased oxidative stress in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

In situ detection of lipid peroxidation by-products in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900266-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00266-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9825737%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77590570&oldid=1385316026"